DCF — BEAUMONT HEALTH - TRENTON
Enterprise Value: $32.9M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$32.9M
Enterprise Value
$4.4M
PV of Cash Flows
$28.5M
PV of Terminal Value
$45.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $210.6M | $8.3M | 4.0% | $-1.4M | $-1.2M |
| Year 2 | $216.9M | $10.7M | 5.0% | $0.2M | $0.2M |
| Year 3 | $223.5M | $13.3M | 6.0% | $1.9M | $1.4M |
| Year 4 | $230.2M | $14.8M | 6.0% | $2.8M | $1.9M |
| Year 5 | $237.1M | $15.9M | 7.0% | $3.4M | $2.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $32.9M. Terminal value accounts for 87% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$204.5M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.03447818392939375
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5